Generic tamsulosin put to the test: are they truly equal?
NCT ID NCT07698288
First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time
Summary
This study checks whether a test version of tamsulosin 0.4 mg prolonged-release tablets works the same as a reference version in healthy men aged 18 to 55. Participants take a single dose of each tablet on separate occasions after a meal, and researchers measure drug levels in the blood to see if they match. The goal is to confirm bioequivalence, which could support the use of a more affordable alternative.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tamsulosin
- What this could lead to
- If the test tablet is shown to work the same as the reference, it could offer a more affordable or accessible option for treating enlarged prostate symptoms.
- What could go wrong
- This is a small, early-stage bioequivalence study in healthy volunteers, not patients. Results may not predict real-world effectiveness or safety differences.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOEQUIVALENCE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Axis Clinicals Latina, S.A. de C.V.
Mexico City, Mexico City, 07870, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.